Skip to main content
Mobile
  • Finance, Accounting & Economics
  • Global Business Management
  • Management, Leadership & Organisation
  • Marketing & Sales
  • Strategy
  • Technology & Operations
HS Talks HS Talks
Subjects  
Search
  • Notifications
    Notifications

    No current notifications.

  • User
    Welcome Guest
    You have Limited Access The Business & Management Collection
    Login
    Get Assistance
    Login
    Forgot your password?
    Login via your organisation
    Login via Organisation
    Get Assistance
Finance, Accounting & Economics
Global Business Management
Management, Leadership & Organisation
Marketing & Sales
Strategy
Technology & Operations
You currently don't have access to this journal. Request access now.
Practice paper

Positioning infectious disease physician leaders to promote patient safety, mitigate risk: A cost avoidance revenue model

Susan C. Bleasdale
Management in Healthcare: A Peer-Reviewed Journal, 4 (3), 258-264 (2020)
https://doi.org/10.69554/IDUK2938

Abstract

With the increase in the number of Medicare beneficiaries, more cost-efficient care is needed to preserve the Medicare budget. Centers for Medicare and Medicaid have instituted value-based purchasing (VBP) to reduce healthcare costs and improve patient outcomes. The VBP programme has incentivised healthcare systems to allocate resources and effort to decrease healthcare-acquired conditions (HACs). Initial HACs were heavily weighted in infection-related conditions, and improvements have been actualised through infectious disease leadership. The VBP programme is anticipated to expand to new domains in antimicrobial stewardship (AS) with the addition of AS programmes to the hospitals’ conditions of participation. The VBP programme along with other evidence demonstrates that infectious disease care and leadership leads to improved patient outcomes and decreased healthcare costs. Healthcare systems should assess current infectious disease physician engagement and optimise the utilisation of this expertise to improve outcomes for a more cost avoidance revenue model.

Keywords: value-based purchasing; cost avoidance; infectious diseases leadership; healthcare-acquired conditions (HAC); outpatient parenteral antimicrobial therapy; sepsis; patient outcomes

The full article is available to subscribers to the journal.

Already a subscriber? Login or review other options.

Author's Biography

Susan C. Bleasdale is the interim Chief Quality Officer and the physician lead for infection prevention and antimicrobial stewardship at the University of Illinois Hospital and Health Sciences System (UIH). In administrative roles, she directs initiatives to reduce infections and multidrug- resistant organisms (MDROs) and to improve antimicrobial prescribing. In research, she was the lead investigator for one of the first studies of chlorhexidine gluconate (CHG) use to reduce bloodstream infections. Current research activity is related to the study of interventions to reduce infections and improve antibiotic stewardship and antimicrobial clinical trials. Bleasdale is a lead investigator for a study to reduce surgical site infections as part of the CDC Epicenters for Prevention of Healthcare Associated Infections (HAIs). Prior Epicenter work studied the transmission of HAIs via healthcare workers and the effective use of personal protective equipment to prevent transmission. In addition, she is currently working on inpatient and ambulatory antimicrobial stewardship interventions. Her clinical practice is general infectious disease and HIV care. She has activities related to infectious disease policy, advocacy and guidelines through leadership roles in the Infectious Disease Society of America (IDSA) and the Society for Healthcare Epidemiology of America. She is the current chair of the IDSA Clinical Affairs Committee.

Citation

Bleasdale, Susan C. (2020, March 1). Positioning infectious disease physician leaders to promote patient safety, mitigate risk: A cost avoidance revenue model. In the Management in Healthcare: A Peer-Reviewed Journal, Volume 4, Issue 3. https://doi.org/10.69554/IDUK2938.

Options

  • Download PDF
  • Share this page
    Share This Article
    Messaging
    • Outlook
    • Gmail
    • Yahoo!
    • WhatsApp
    Social
    • Facebook
    • X
    • LinkedIn
    • VKontakte
    Permalink
cover image, Management in Healthcare: A Peer-Reviewed Journal
Management in Healthcare: A Peer-Reviewed Journal
Volume 4 / Issue 3
© Henry Stewart
Publications LLP

The Business & Management Collection

  • ISSN: 2059-7177
  • Contact Us
  • Request Free Trial
  • Recommend to Your Librarian
  • Subscription Information
  • Match Content
  • Share This Collection
  • Embed Options
  • View Quick Start Guide
  • Accessibility

Categories

  • Finance, Accounting & Economics
  • Global Business Management
  • Management, Leadership & Organisation
  • Marketing & Sales
  • Strategy
  • Technology & Operations

Librarian Information

  • General Information
  • MARC Records
  • Discovery Services
  • Onsite & Offsite Access
  • Federated (Shibboleth) Access
  • Usage Statistics
  • Promotional Materials
  • Testimonials

About Us

  • About HSTalks
  • Editors
  • Contact Information
  • About the Journals

HSTalks Home

Follow Us On:

HS Talks
  • Site Requirements
  • Copyright & Permissions
  • Terms
  • Privacy
  • Sitemap
© Copyright Henry Stewart Talks Ltd

Personal Account Required

To use this function, you need to be signed in with a personal account.

If you already have a personal account, please login here.

Otherwise you may sign up now for a personal account.

HS Talks

Cookies and Privacy

We use cookies, and similar tools, to improve the way this site functions, to track browsing patterns and enable marketing. For more information read our cookie policy and privacy policy.

Cookie Settings

How Cookies Are Used

Cookies are of the following types:

  • Essential to make the site function.
  • Used to analyse and improve visitor experience.

For more information see our Cookie Policy.

Some types of cookies can be disabled by you but doing so may adversely affect functionality. Please see below:

(always on)

If you block these cookies or set alerts in your browser parts of the website will not work.

Cookies that provide enhanced functionality and personalisation. If not allowed functionality may be impaired.

Cookies that count and track visits and on website activity enabling us to organise the website to optimise the experience of users. They may be blocked without immediate adverse effect.